S&P 500 Futures
(0.15%) 5 335.00 points
Dow Jones Futures
(0.09%) 40 175 points
Nasdaq Futures
(0.21%) 18 674 points
Oil
(0.25%) $80.26
Gas
(1.83%) $2.67
Gold
(1.51%) $2 453.80
Silver
(3.75%) $32.43
Platinum
(0.87%) $1 099.50
USD/EUR
(-0.11%) $0.919
USD/NOK
(-0.15%) $10.66
USD/GBP
(-0.01%) $0.787
USD/RUB
(0.13%) $91.09

Realtime updates for Anterogen.Co.,Ltd. [065660.KQ]

Exchange: KOSDAQ
Last Updated20 May 2024 @ 01:26

-2.02% KRW 15 060

Live Chart Being Loaded With Signals

Commentary (20 May 2024 @ 01:26):

Anterogen.Co.,Ltd., a bio-venture company, engages in the research, development, and commercialization of stem cell therapy products using adipose-derived stem cells in South Korea and internationally...

Stats
Today's Volume 18 410.00
Average Volume 45 873.00
Market Cap 146.55B
EPS KRW0 ( 2021-01-29 )
Last Dividend KRW0 ( N/A )
Next Dividend KRW0 ( N/A )
P/E 0
ATR14 KRW16.63 (0.11%)

Volume Correlation

Long: -0.26 (neutral)
Short: -0.23 (neutral)
Signal:(57.309) Neutral

Anterogen.Co.,Ltd. Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Anterogen.Co.,Ltd. Correlation - Currency/Commodity

The country flag -0.08
( neutral )
The country flag 0.55
( weak )
The country flag 0.47
( neutral )
The country flag 0.84
( strong )
The country flag 0.00
( neutral )
The country flag 0.54
( weak )

Anterogen.Co.,Ltd. Financials

Annual 2023
Revenue: KRW6.50B
Gross Profit: KRW2.21B (34.05 %)
EPS: KRW-291.93
FY 2023
Revenue: KRW6.50B
Gross Profit: KRW2.21B (34.05 %)
EPS: KRW-291.93
FY 2022
Revenue: KRW6.59B
Gross Profit: KRW2.62B (39.70 %)
EPS: KRW-705.88

Financial Reports:

No articles found.

Anterogen.Co.,Ltd. Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Anterogen.Co.,Ltd.

Anterogen.Co.,Ltd., a bio-venture company, engages in the research, development, and commercialization of stem cell therapy products using adipose-derived stem cells in South Korea and internationally. The company offers medicines, including Cupistem injection, an adipose stem cell product that is used for the treatment of Crohn's fistula; Queencell, a stromal vascular fraction used for the regeneration of subcutaneous adipose tissue; and Remodulin injection, a medicine for the treatment of pulmonary arterial hypertension. It also provides cosmetics, such as hair care products comprising SCM2 and SCM2-Black; and skin care products, such as Therastem-Derma, Therastem-White Silk, and Therastem-White Glutathione, as well as human stem cell conditioned media, a cosmetic raw material. In addition, the company offers cell banking services; and analysis services that include sample analysis for clinical studies, as well as conducts biopharmaceutical tests for identification, purity, potency, adventitious virus, etc. Anterogen.Co.,Ltd. was founded in 2000 and is headquartered in Seoul, South Korea.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators